A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)

• Sponsor: University of Rochester (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT04824859
• Collaborator: (none)
• Enrollment: 50
• Location: 1
• Arm: 1
• Anticipated Duration (Months): 6.7
• Patients Per Site Per Month: 7.4

Study Details

Study Description

Brief Summary

This project assesses the feasibility and usability of the geriatric assessment platform (electronic Geriatric Assessment Platform or eGAP in 50 older patients with cancer, their caregivers, and their oncology team. Using an iterative process, we will refine the eGAP based on input from stakeholders.

Condition or Disease	Intervention/Treatment	Phase
Cancer	Behavioral: Behavioral	N/A

Detailed Description

A geriatric assessment is a multidisciplinary diagnostic process that can detect medical, psychosocial and functional problems not identified by routine evaluation. This can subsequently guide management of the identified problems. However, the time and resources required to incorporate a geriatric assessment into clinic visits remain the primary barriers for implementation. There is a need to increase the adoption of the geriatric assessment among general oncologists and to address the associated resource limitations. Our long-term goal is to utilize an electronic platform to facilitate completion of the geriatric assessment. This project assesses the feasibility and usability of the geriatric assessment platform (electronic Geriatric Assessment Platform or eGAP) in 50 older patients with cancer, their caregivers, and oncology providers. Using an iterative process, we will refine the eGAP based on input from stakeholders (patients, caregivers, oncologists, nurses, advanced practitioners)

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 50 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Intervention Model Description: Electronic geriatric assessment platform to collect data (e.g., functional status, comorbidity, psychological health) that may better reflect health status of older adults with cancerElectronic geriatric assessment platform to collect data (e.g., functional status, comorbidity, psychological health) that may better reflect health status of older adults with cancer
• Masking: None (Open Label)
• Primary Purpose: Supportive Care
• Official Title: A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)
• Actual Study Start Date: Dec 7, 2021
• Anticipated Primary Completion Date: Jun 30, 2022
• Anticipated Study Completion Date: Jun 30, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Experimental The eGAP consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on patient responses, tailored recommendations will be provided.	Behavioral: Behavioral; eGAP that allows patients to complete validated questionnaires, and these questionnaires will be summarized and recommendations provided to the treating team

Outcome Measures

Primary Outcome Measures

1. Feasibility Retention Rate [1 week]

   Percentage of patients completing the assessments that are assigned to them on eGAP

Secondary Outcome Measures

1. Recruitment rates [1 week]

   Percentage of patients who are approached and agree to enroll

2. Self-Report Completion Time [1 week]

   Time spent on completing the self-reported assessments on the eGAP

3. System Usability Scale [1 week]

   For patients, caregivers, and oncology providers: score on 10-item scale, ranging 0-100; higher score corresponds to greater usability

Eligibility Criteria

Criteria

• Ages Eligible for Study: 60 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria for patients:

• Age ≥65 years

• Have a diagnosis of cancer

• Able to provide informed consent

• English-speaking (because the platform is currently in English)

Inclusion criteria for caregivers:

• Age ≥21 years

• Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters".

• Able to provide informed consent

• English-speaking

Inclusion criteria for oncologists:

• Oncologists, APPs, and nurses who care for the patient

Exclusion Criteria:

• N/A

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Rochester	Rochester	New York	United States	14642

Sponsors and Collaborators

• University of Rochester

Investigators

• Principal Investigator: Kah Poh Loh, University of Rochester

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Kah Poh Loh, Senior Instructor, Department of Medicine, Hematology/Oncology, University of Rochester
• ClinicalTrials.gov Identifier: NCT04824859
• Other Study ID Numbers: UCCS21026
• First Posted: Apr 1, 2021
• Last Update Posted: Dec 23, 2021
• Last Verified: Dec 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Yes
• Plan to Share IPD: Yes
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Kah Poh Loh, Senior Instructor, Department of Medicine, Hematology/Oncology, University of Rochester: Supportive Care; Cancer; mHealth; Geriatric

Study Results

No Results Posted as of Dec 23, 2021